GF Fund Management’s MacroGenics MGNX Stock Holding History

GF Fund Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,303	Closed	-$2.19K	–	676
2025 Q3	$2.19K	Sell	1,303 -254	-16%	-$411	﹤0.01%	623
2025 Q2	$1.88K	Hold	1,557	–	–	﹤0.01%	648
2025 Q1	$1.98K	Buy	1,557 +239	+18%	+$624	﹤0.01%	649
2024 Q4	$4.28K	Buy	+1,318	New	+$4.75K	﹤0.01%	615

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

GF Fund Management's MGNX Position: Q4 2025 in Review

GF Fund Management sold out of MacroGenics (MGNX) in Q4 2025, closing a stake of 1,303 shares — an estimated $2.19K sold.

GF Fund Management first reported a position in MGNX in Q4 2024 and held it in 4 quarters. The position peaked at $4.28K in Q4 2024. 88 funds tracked by Wall St. Rank hold MGNX as of Q4 2025.

GF Fund Management reported no remaining MacroGenics position as of Q4 2025 after selling out during the quarter.
GF Fund Management sold 1,303 MacroGenics shares in Q4 2025, an estimated $2.19K.
GF Fund Management first reported a position in MacroGenics in Q4 2024 and held it in 4 quarters.
GF Fund Management's MacroGenics position peaked at $4.28K in Q4 2024.
88 funds tracked by Wall St. Rank held MacroGenics as of Q4 2025.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.